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ABSTRACT
Methylation is a common modification encountered
in DNA, RNA and proteins. It plays a central role in
gene expression, protein function and mRNA trans-
lation. Prokaryotic and eukaryotic class I translation
termination factors are methylated on the glutamine
of the essential and universally conserved GGQ
motif, in line with an important cellular role. In eu-
karyotes, this modification is performed by the
Mtq2-Trm112 holoenzyme. Trm112 activates not
only the Mtq2 catalytic subunit but also two other
tRNA methyltransferases (Trm9 and Trm11). To
understand the molecular mechanisms underlying
methyltransferase activation by Trm112, we have
determined the 3D structure of the Mtq2-Trm112
complex and mapped its active site. Using site-
directed mutagenesis and in vivo functional experi-
ments, we show that this structure can also serve as
a model for the Trm9-Trm112 complex, supporting
our hypothesis that Trm112 uses a common
strategy to activate these three methyltransferases.
INTRODUCTION
Methylation is a widespread modiﬁcation occurring on a
large variety of substrates. Among these, components
linked to protein synthesis (rRNA, tRNA, ribosomal
proteins and translational factors) seem to be over-
represented (1,2). In most instances, this modiﬁcation is
catalysed by S-adenosylmethionine- (SAM)-dependent
methyltransferases (MTases), whose larger family (class I)
consists of a seven-stranded b-sheet surrounded by helices
on each side (3). The fold of the members of this family is
well conserved despite little sequence identity.
Among the various substrates of protein MTases
identiﬁed so far, the universally conserved GGQ motif
found in class I translation termination factors is of par-
ticular interest. This motif becomes N5-methylated on the
glutamine (Gln) side chain in both prokaryotes and eu-
karyotes (4,5), although the factors from these two
kingdoms are structurally unrelated (6,7). These proteins
(RF1 and RF2 in bacteria and eRF1 in eukaryotes) rec-
ognize stop codons entering the ribosomal A-site and
induce the hydrolysis of the ester bond connecting the
newly synthesized polypeptide to the P-site tRNA (8).
Hydrolysis is catalysed by the peptidyl transferase centre
(PTC) of the large ribosomal subunit and this step
requires the entry of the GGQ motif into the PTC (9–11).
In Escherichia coli, the MTase PrmC catalyses the Gln
modiﬁcation (12,13). PrmC comprises two domains:
an N-terminal ﬁve-helix bundle connected by a short
b-hairpin to a large C-terminal domain characteristic of
the class I SAM–dependent MTases (14,15). The crystal
structure of the complex between E. coli RF1 and PrmC
has revealed that this MTase is speciﬁc for the closed form
of RF1 (14). This methylation is clearly necessary for ef-
ﬁcient bacterial translation termination in vivo, since prmC
inactivation reduces the speciﬁc termination activity of
RFs 3- to 4-fold. In E. coli, K12 strains, which carry a
mutation reducing RF2 activity, lack of methylation is no
longer compatible with normal cell growth. In strains with
normal RF2 activity, prmC inactivation considerably
reduces growth on poor carbon sources, suggesting that
lack of RF methylation limits the synthesis of some
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Similar results were obtained in vitro, where the efﬁciency
of termination with unmethylated RF2 is at least three
times lower than with methylated (4). Recent high-
resolution crystal structures of 70S ribosome termination
complexes bound with RF1 or RF2 and mRNA contain-
ing a stop codon have revealed the mechanism of stop
codon recognition and the concomitant strict coordin-
ation of peptidyl-tRNA hydrolysis (10,11,17). The struc-
ture of RF1 bound to a pre-termination complex revealed
that the Gln side chain from the GGQ motif may directly
coordinate the catalytic water molecule through its
carbonyl oxygen, conﬁrming previous molecular dynamics
studies (10,18). Methylation of this side chain would sta-
bilize the entire hydrogen bonding network within the
PTC and improve RF1/RF2 afﬁnity for the ribosome by
increasing hydrophobic interactions (10), rationalizing
previous in vitro experiments showing that over-expressed
RF2 had a lower afﬁnity to the ribosome than the
methylated factor (19).
Methylation of the GGQ motif is conserved in both
Saccharomyces cerevisiae and mammalian eRF1 proteins
(5,20). This modiﬁcation is performed by a heterodimeric
holoenzyme: Mtq2/Trm112, Pred28a (N6amt1)/mTrm112
and HEMK2a/hTRM112 in yeast, mouse and man, re-
spectively (hereafter referred to as Mtq2-Trm112)
(5,20,21). In this complex, the Mtq2 subunit binds the
SAM cofactor and catalyses methyl transfer while the
Trm112 partner stabilizes and activates Mtq2 (21,22).
Trm112 is a small protein composed of two domains: a
conserved zinc-binding domain formed by both N- and
C-terminal extremities and a central helical domain
speciﬁc to eukaryotes (22). The Mtq2-Trm112 substrate
is the eRF1-eRF3-GTP (or any non-hydrolysable GTP
analogue) complex, where eRF3 is the class II release
factor of the translational GTPase family, which assists
eRF1 in peptide release by inducing a rearrangement of
the termination complex upon GTP hydrolysis (22–24). As
in prokaryotes, the role of this methylation seems to be
associated with the ribosome environment, since methyla-
tion should not affect the intrinsic structure of eRF1 (25).
Deletion of the MTQ2 gene in S. cerevisiae affects growth
(2-fold decrease in growth rate at 30 C) and leads to sen-
sitivity to the antibiotic paromomycin, implying a trans-
lation defect related to ribosomal A site function (26)
(V.H.H. and S.F., unpublished results). In addition, in-
activation of the murine N6amt1 gene leads to early em-
bryonic lethality probably due to cell cycle defects (20).
The S. cerevisiae trm112- strains are sicker than mtq2-
strains, indicating that Trm112 has additional functions
(27) (V.H.H. and S.F., unpublished results). In parallel,
inactivation of SMO2, encoding the Trm112 homolog in
Arabidopsis thaliana, leads to a defect in progression of
cell division and organ growth (28).
Besides Mtq2, Trm112 interacts with and activates two
other MTases: Trm9 and Trm11 (22,27,29–32). The Trm9-
Trm112 complex catalyses the addition of a methyl group
to uridine at wobble position (U34) of some tRNAs
(tRNA
ARG(UCU) and tRNA
GLU(UUC)) (33,34). These
modiﬁed tRNAs are the speciﬁc targets of zymocin, a
tRNAse toxin secreted by Kluyveromyces lactis (35).
Consequently, disruption of TRM9 or TRM112 genes
renders strains resistant to that toxin (36). In addition,
yeast Trm9 has been implicated in cell death protection
by enhancing the translation of DNA damage response
key proteins (37). The Trm11-Trm112 complex methylates
guanine at position 10 on several yeast tRNAs, forming
2-methylguanosine (30,31).
To gain insight into the role of Trm112 in the activation
of these three MTases, we have solved the crystal structure
of eukaryotic Mtq2-Trm112 MTase bound to its cofactor
SAM and performed in vitro biochemical analysis of
mutants as well as in vivo studies. This has allowed us to
identify an activation mechanism and to propose a model
explaining the need for GTP in the methylation reaction.
In addition, in vivo mutational analysis supports the idea
that yeast Trm9 interacts with Trm112 in a similar way as
Mtq2, rationalizing the role of Trm112 as an activating
platform for several MTases.
MATERIALS AND METHODS
Cloning, mutagenesis, expression and puriﬁcation of
proteins
Genes encoding Encephalitozoon cuniculi (Ec)-Mtq2
(UniProtKB entry: Q8SRR4), eRF1 and eRF3 were
cloned from Ec-GB-M1 genomic DNA (generous gift from
P r o f .V i v a r e s ,U n i v e r s i t e ´ Blaise Pascal, Clermont-Ferrand,
France) into pET9 plasmids with a C-terminal hexahistidine
tag. In parallel, a DNA sequence was designed to encode
Ec- Trm112 (UniProtKB entry: Q8SUP0) and Mtq2 with a
C-terminus His-tag. This fragment was obtained by de novo
gene synthesis (GenScript Corporation, Piscataway, NJ,
USA) and was further subcloned into pET21-a between
NdeI and XhoI sites. Expression of the His-tagged
Mtq2-Trm112 complex was done in E. coli BL21 (DE3)
Gold strain (Novagen). The 800ml of culture in 2xYT
medium (BIO101 Inc.) containing ampicillin at 50mg/ml
were incubated at 37 C until an OD600 of about 0.6–0.8
and induced with IPTG 0.5mM ﬁnal at 28 C for 4h. The
cells were harvested by centrifugation, resuspended in
40ml of 20mM Tris–HCl, pH 7.5, 200mM NaCl, 5mM
b-mercaptoethanol (buffer A) and stored at  20 C. Cell
lysis was achieved by sonication. His-tagged complex was
puriﬁed on a nickel-nitrilotriacetic acid column (Qiagen
Inc.) followed by gel ﬁltration on a SuperdexTM 75 (16/
60) column (GE Healthcare) equilibrated in buffer A.
Plasmids used for over-expression of yeast proteins were
mutagenized following Quick change mutagenesis
protocol (Stratagen) and sequenced. Expression and puri-
ﬁcation of S. cerevisiae and human proteins were done as
described previously (21,22).
Yeast strain construction
Genomic cassette insertion through homologous recom-
bination was used for C-terminus epitope-tagging in
yeast according to published protocol (38). Point muta-
tions in Trm9-13Myc encoding gene sequence were also
introduced by cassette insertion through homologous re-
combination (39). Detailed experimental procedure is
described in Supplementary Data.
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Soluble protein extracts were prepared by the glass bead
method starting from 10
8 to 10
9 mid-log growing cells.
Cells were washed once in water and pellets were frozen
in liquid nitrogen and then stored at  20 C. Cells were
thawed and resuspended in ice-cold breaking buffer
(50mM Tris–HCl, pH 7.5, 150mM NaCl, 20mM
MgCl2, 5mM EDTA, 1% NP-40) supplemented with
Complete EDTA-free anti-protease cocktail (Roche
Diagnostics). After addition of acid-washed glass beads,
cells were lysed by 5 pulses of vortexing for 30s separated
by cooling intervals on ice. Soluble fractions were col-
lected after centrifugation for 20min at 4 Ca t
13000rpm. Based on Bradford assay, 500mg of proteins
were incubated with mouse monoclonal 9E10 anti-myc
antibody (Santa Cruz Biotechnology) for 1h on ice.
Immune complexes were then incubated for 30min at
4 C on a rotating wheel after addition of protein
G-agarose (Sigma). Agarose beads were washed four
times in breaking buffer. The ﬁnal pellet was resuspended
in cracking buffer (40mM Tris–HCl, pH 6.8, 8M Urea,
5% SDS, 0.1mM EDTA, 1% b-mercaptoethanol, 0.04%
Bromophenol Blue) (40) and boiled for protein release
from beads. Proteins from starting soluble fraction and
from ﬁnal supernatant were resolved on a 15% polyacryl-
amide gel and transferred onto Protran nitrocellulose
membrane (Whatman). Probing was performed using
either mouse 9E10 anti-myc or 12CA5 anti-HA (Santa
Cruz Biotechnology) as primary antibody (1/500) and
sheep anti-mouse HRP-conjugated IgG as secondary
antibody (1/3000, GE HealthCare). Immunoblots were
developed using ECL (GE HealthCare).
Zymocin killer assay
This assay was performed as previously described (41).
Procedure is described in Supplementary Data.
Crystallization and structure solution
Thin needle crystals were grown at 19 C from a 0.1:0.1ml
mixture of 7mg/ml complex solution with a crystallization
solution containing 20% poly ethylene glycol (PEG) 4000,
10% isopropanol, 100mM HEPES (pH 7.5). For data
collection, the crystals were transferred into a cryoprotect-
ant crystallization solution with progressively higher
ethylene glycol concentrations up to 30% v/v. The
datasets were collected at the Zn-edge on beam line
Proxima-1 (SOLEIL, St-Aubin, France). The structure
was determined by the SAD method (Single wavelength
Anomalous Dispersion) using the anomalous signal from
the Zn element (see Supplementary Data for details).
The ﬁnal model contains all the Mtq2 residues (from
Met1 to Ser164) as well as residues 1–32 and 36–125
from Trm112, which are well deﬁned in electron density.
In addition, one zinc atom, one SAM molecule and 136
water molecules have been modelled. Statistics for data
collection and reﬁnement are summarized in
Supplementary Table S1. The atomic coordinates and
structure factors have been deposited into the
Brookhaven Protein Data Bank under the accession
number 3Q87.
In vitro methylation assay
Methylation assays were done as described previously by
incubating eRF1, eRF3 and GTP with Mtq2-Trm112
complex in presence of [
3H] SAM (22).
SAM-binding to human Mtq2 (Hs-Mtq2)
An equimolar amount of Hs-Trm112 was added to par-
tially puriﬁed Hs-Mtq2 (corresponding approximately to
100pmol) and 0.5mlo f[
3H] SAM (78Ci/mmol, Perkin
Elmer) in 50ml ﬁnal volume methylation buffer for 15min
at 30 C. Reaction was stopped by ﬁltration through nitro-
cellulose ﬁlters (0.45mm HAWP02500 Millipore) followed
by washing with methylation buffer. Radioactivity on
ﬁlter then represents an amount of SAM bound to
Hs-Mtq2. Controls with Hs-Trm112 alone showed very
low background ﬁxation. We checked by western blot
that Hs-Trm112 was not increasing binding of Hs-Mtq2
itself to the ﬁlter, increasing artifactually SAM-binding.
RESULTS
Crystal structure
To understand the molecular basis responsible for the
interaction between Mtq2 and Trm112, we have crystal-
lized the Mtq2-Trm112 complex from the small parasite
E. cuniculi (Ec-Mtq2-Trm112, see ‘Cloning, mutagenesis,
expression and puriﬁcation of proteins’ for more details).
We took advantage of the presence of a zinc atom bound
to Trm112 as observed for the S. cerevisiae protein (22) to
solve the structure of this complex by the SAD method
using the zinc anomalous signal. The ﬁnal model has been
reﬁned to 2.1 A ˚ resolution and contains one Mtq2-
Trm112 heterodimer in the crystal asymmetric unit
(Figure 1A, Supplementary Table S1 and Figure S1 for
electron density map). Although we did not pre-incubate
the Mtq2-Trm112 complex with SAM for the crystalliza-
tion experiments, an unambiguous electron density corres-
ponding to a SAM molecule is present in its expected
binding site, indicating that this ligand was co-puriﬁed
with the complex. SAM is bound at the C-terminal face
of the Mtq2 central b-sheet and interacts exclusively with
residues from Mtq2.
Mtq2 adopts the typical class I SAM-dependent MTase
fold composed of a central seven-stranded b-sheet (strand
order: b3"b2"b1"b4"b5"b7#b6") surrounded by three
a-helices (a1–a3) on one side and two (a4 and a5) on
the other (42). A search for proteins with similar three-
dimensional structure [program DALI (43)] identiﬁed the
C-terminal domain MTase from the PrmC/HemK as the
best hit (Z-score=18.5; RMSD of 2.2 A ˚ over 159 Ca
atoms, 19% sequence identity) (14,44). Interestingly, this
enzyme performs the same chemical reaction as Mtq2,
since it modiﬁes the Gln side chain of the GGQ motif
from bacterial release factors RF1 and RF2. The bacterial
PrmC MTases are formed by an N-terminal helical
domain and a C-terminal MTase domain connected by a
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only the MTase domain is present in Mtq2. In proteins
from both kingdoms, these domains are very similar and
bind the SAM/S-adenosyl-L-homocysteine (SAH) cofactor
in the same way.
The Ec-Trm112 protein is composed of two domains: a
zinc-binding domain formed by both N- and C-terminal
extremities and a central domain. Its overall structure is
very similar to yeast Trm112 [Z-score=9.3 and global
RMSD of 2.9 A ˚ over 102 Ca atoms, 18% sequence
identity; Supplementary Figure S2A, (22)]. The zinc-
binding domain consists of an a-helix packed onto a
four-stranded antiparallel b-sheet (RMSD with the
equivalent domain from yeast Trm112 of 1.4 A ˚ over 57
Ca atoms, 30% sequence identity). Similarly, to yeast
Trm112, four cysteine residues coordinate the zinc atom.
The central domain is a four-helix bundle in the E. cuniculi
protein but it is less similar to yeast Trm112 (three-helix
bundle) than the zinc-binding domain (RMSD of 3.4 A ˚
over 42 Ca atoms, 5% sequence identity). In this domain,
only helices a3 and a4 from Ec-Trm112 match with the
equivalent helices from yeast Trm112. Helix a2 from the
yeast protein structurally matches with the elongated
stretch preceding helix a2 in Ec-Trm112. Helix a30 from
Ec-Trm112 corresponds to the linker connecting helices a3
and a4 in yeast protein. Another important difference
between the E. cuniculi and yeast Trm112 structures
resides in the orientation of the last ten C-terminal
residues that are relatively well conserved. This region
was proposed to be part of the homodimer interface in
yeast Trm112 and this has since been conﬁrmed by
site-directed mutagenesis (data not shown). In the
present Mtq2-Trm112 complex, this region cannot adopt
the same conformation and folds back onto Trm112
strand b3 to avoid important steric clashes
(Supplementary Figure S2B).
Mtq2-Trm112 interface
In the complex, Mtq2 binds mainly to the zinc-binding
domain from Trm112 via a b-zipper interaction between
Mtq2 strand b3 and Trm112 strand b4 that are associated
in a parallel manner (Figure 1A). As a consequence, their
b-sheets form a continuous large eleven-stranded b-sheet.
Additional contacts are also made by residues from
the loop connecting strands b3t ob4 in Mtq2 with helix
a1 and the a1-b1 loop from Trm112 (Supplementary
Figures S3A–C, S4 and S5). The complete interface
buries a total solvent accessible surface area of 2000 A ˚ 2
and contains 12 hydrogen bonds, clustered in two regions
(see Supplementary Table S2). H-bonds at the b-zipper
interface are mostly realized between main chain atoms
from both partners (Supplementary Figure S3A).
Additional H-bonds occur between residues from loop
connecting b1t oa2 in Trm112 and from loop b3-b4i n
Mtq2 (Supplementary Figure S3B). Non-polar atoms clus-
tered at the centre of this contact area provide two-thirds
of the interface (Supplementary Figure S3B–C). This is
indeed illustrated by the strictly conserved Ile
125
(S. cerevisiae numbering) from Trm112 strand b4. Its sub-
stitution by an aspartic residue results in complete inacti-
vation without disrupting the Mtq2-Trm112 complex
(Table 1). A few contacts also exist between strand b2a s
well as the b3–b4 loop in Mtq2 and the loop connecting b1
to a2 from the Ec-Trm112 central domain. Helix a2
in yeast Trm112 matches with the region corresponding
to the Ec-Trm112 b1-a2 loop and hence is predicted to
be important for Mtq2-Trm112 complex formation
(Supplementary Figure S3C). This is supported by experi-
ments showing that the yeast complexes containing yeast
Trm112 single point mutants F46D and R53E are less
A
Mtq2
Trm112
Ct
1
2
3
4
1
1 2
2
3
3
4
4
5
7
6
5
4
3'
3 1
2
B
D69
L70
C
Figure 1. Mtq2 activation by Trm112. (A) Ribbon representation of
the E. cuniculi Mtq2 (blue)-Trm112 complex. The Trm112 zinc-binding
and central domains are shown in pink and green, respectively. The
purple sphere depicts the zinc atom bound to Trm112. The SAM
cofactor bound to Mtq2 is shown as yellow sticks. Secondary structure
elements are indicated. Labels in italics correspond to Trm112.
(B) Activation loop. Same colour code as panel (A). The loop connect-
ing strands b3t ob4 from Mtq2 is shown in grey. Black dashed lines
depict hydrogen bonds. The SAM cofactor bound to Mtq2 is shown as
yellow ball and sticks. (C) Effect of HsTrm112 on SAM-binding by
HsMtq2. The lower SAM-binding activity observed for the complex
formed by the two proteins puriﬁed separately is probably due to the
instability of the HsMtq2 protein. Hence, contrary to the co-expressed
and copuriﬁed HsMtq2-Trm112 complex, which is very stable, a
signiﬁcant fraction of HsMtq2 should not be functional in this assay.
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lost eRF1 MTase activity (Table 1). In addition, superpos-
ition of yeast Trm112 onto our structure of the complex
suggests that additional contacts could occur between
helix a2 from Sc-Trm112 and the N-terminal face of the
Mtq2 b-sheet as it faces two loops (connecting a1t ob1
and a2t ob2) that are predicted to be longer in other
organisms such as S. cerevisiae than in E. cuniculi. This
is supported by the N43R mutant, which has decreased
eRF1 MTase activity (Supplementary Figure S3C and
Table 1).
Trm112 enhances SAM-binding by Mtq2
Trm112 is needed to solubilize and activate Mtq2 in yeast
(22). Similarly, human Mtq2 (Hs-Mtq2) protein performs
eRF1 methylation only after incubation with human
Trm112 (21). In order to understand the mechanism of
Mtq2 activation by Trm112, we used the structure of the
complex to examine the effect of site-directed mutations.
Our strategy is based upon two important observations.
First, Trm112 shields from the solvent a large hydropho-
bic surface from Mtq2 by using a hydrophobic region that
is involved in yeast Trm112 homodimer formation, ex-
plaining why Trm112 solubilizes Mtq2 (Supplementary
Figure S3D–E), (22). Second, the loop connecting
strands b3–b4 in Mtq2, which is largely involved in the
interaction with Trm112, is also involved in SAM-binding
(Figure 1B). This led us to speculate that although it does
not interact directly with SAM, Trm112 may stabilize this
loop in a conformation allowing Mtq2 to bind more
tightly the SAM cofactor. In particular, the Asp
69 side
chain and Leu
70 main chain amide groups from this
loop are hydrogen-bonded to the adenine moiety of
SAM. We have therefore assessed the importance of
these two residues for MTase activity by site directed mu-
tagenesis of the corresponding residues in yeast Mtq2
protein (Asp
106/Leu
107). Co-expression of this double
mutant (D106A/L107A) with Trm112 yielded soluble
complex, indicating that these mutations do not prevent
complex formation. Similarly to the D77A mutant (Asp
51
in E. cuniculi), a mutation known to disrupt SAM-binding
by MTases, the D106A/L107A, a double mutant is com-
pletely unable to methylate eRF1 (Table 1). We next took
advantage of the fact that Hs-Mtq2, in contrast with
Sc-Mtq2, can be puriﬁed in low amounts following
over-expression in E. coli in the absence of Hs-Trm112
(21). Although this protein is well folded according to
circular dichroism experiments (data not shown), it is
unable to methylate eRF1 on its own (21). This could
be due to its intrinsically low SAM-binding activity
(Figure 1C). Incubation of this protein with an equimolar
amount of Hs-Trm112 resulted in restoration of SAM-
binding activity (Figure 1C). It is noteworthy that
Hs-Trm112 is more efﬁcient when co-expressed with
Hs-Mtq2 than upon incubation of the separately puriﬁed
proteins (Figure 1C). Hence, at least for human proteins,
Trm112 strongly stimulates SAM-binding to Mtq2, a
prerequisite for enzymatic activity.
MTase active site
Mapping of sequence conservation at the surface of the
Mtq2-Trm112 heterodimer clearly identiﬁes a strongly
conserved patch centred on the SAM methyl group
as an excellent candidate for the Mtq2 active site
(Figure 2A). In addition, the absence of longer loops in
orthologous proteins within this putative active site led us
to speculate that this structure is an excellent template for
the design of mutants from yeast Mtq2 that will affect
eRF1 MTase activity.
Superposition of the PrmC-RF1 and Mtq2-Trm112
complexes shows that this conserved region corresponds
to the bacterial PrmC active site (14). In particular, the
Asn-Pro-Pro-Tyr (NPPY) signature found in PrmC but
also in DNA N6-adenine and N4-cytosine MTases mod-
ifying nitrogens conjugated to planar systems such as an
amide group or a nucleotide base (3), matches perfectly
the corresponding signature in Mtq2 (Figure 2B). In the
complex between PrmC and RF1, this motif forms
H-bonds with the Gln side chain of the GGQ motif and
positions it ideally for subsequent methylation (14,15).
As observed for bacterial PrmC, the Asn
122 (Asn
85 in
Ec-Mtq2) side chain in this NPPY signature is crucial
Table 1. Effect of Mtq2 and Trm112 mutants on eRF1 methylation
in vitro
eRF1 MTase
activity (%)
Trm112 mutants
N43R (D36) 58±6 Located in
Ec-Trm112-Mtq2
interface
F46D (I39) 0
R53E (T46) 0
I125D (I115) 0
A106E (V96) 59±11 Outside from
Ec-Mtq2-Trm112
interface
E107K (E97) 61±3
I118E (I108) 51±8
Y120E (P110) 74±3
N123R (G113) 58±1
Mtq2 mutants
E16K (E5) 15±3 Active site
Y15F (Y4) 0
E19K (E8) 0
D20N (D9) 0
F22A (Y11) 0
D26K/E29K (D15/E18) 0
N122A (N85) 0
R207A (R149) 6.5±2.1
R207E (R149) <2
E212K (E154) 65±6
D77A (D51) 0 SAM binding
D106A/L107A (D69/L70) 0
All these Mtq2 mutants were co-expressed with wild-type Sc-Trm112 in
E. coli and puriﬁed using standard protocols. With the exception of the
F22A mutant, none of these mutations affected signiﬁcantly complex
formation, solubility and CD spectra (data not shown). Although its
CD spectrum was comparable to that of wild-type complex, the Mtq2
(F22A)-Trm112 mutant complex was less stable than wild-type
complex. The eRF1 MTase activity of each complex is expressed as a
percentage of activity obtained with wild-type enzyme. Absolute
activities were measured at least in triplicate, as the initial velocity of
the reaction (pmol of eRF1 methylated by second). The E. cuniculi
numbering is indicated in parenthesis.
Nucleic Acids Research, 2011,Vol.39, No. 14 6253AB
C D
Mtq2
RlmA(I)
Trm112
F
R290
K294
R297
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Figure 2. Mtq2 active site. (A) Mapping of the sequence conservation at the surface of the Mtq2-Trm112 complex. The RF1 peptide containing the
GGQ motif (yellow) has been modelled by superimposing the PrmC-RF1 complex onto Mtq2-Trm112 structure. Colouring is from cyan (highly
conserved) to grey (low conservation). (B) Stereo view of the comparison of the Mtq2-Trm112 (blue) and PrmC active sites. The RF1 GGQ motif
is shown as pink sticks. The PrmC MTase domain and the linker connecting N-terminal to MTase domains are coloured yellow and orange,
respectively. The SAM molecule bound to Mtq2 is shown as green sticks. Hydrogen bonds involved in coordination of the RF1 GGQ motif by PrmC
are depicted by dashed lines (14). For clarity, only EcMtq2 residue numbers are indicated. (C) Mapping of the electrostatic potential at the surface of
the Mtq2-Trm112 complex. Positively (10kT/e
 ) and negatively ( 10kT/e
 ) charged regions are coloured in blue and red, respectively. Neutral
regions are in white. The orientation is the same as in panel (A). (D) Mapping of the Mtq2 and Trm112 residues important for eRF1 methylation in
yeast. Mutants affecting partially (>50%), moderately (between 10% and 50%) or completely (<10%) eRF1 methylation are coloured in yellow,
orange and red, respectively. The Mtq2 and Trm112 proteins are coloured pink and beige, respectively. Same orientation as panel (A). (E) Model of
the eRF1-eRF3-GTP complex. The eRF1 GGQ motif is shown in sticks. For clarity, only the central domain from eRF1 is shown (purple). The
GTPase, II and III domains from eRF3 are coloured grey, light green and dark green, respectively. The eRF3 switch regions I and II are coloured
orange and blue, respectively. The GTP bound to eRF3 is shown as grey sticks. This model has been generated by superimposing the eRF3 GTPase
domain and the eRF1 central domain onto the corresponding domains from the recently solved crystal structure of archaeal Pelota/
Dom34-aEF1a-GTP complex (6,24,49). As the switch regions from GTPases are known to adopt the same conformation in the GTP form, we
have assumed that the switch regions from aEF1a and eRF3 are similar in the GTP form to model the conformation of this region in the eRF3 GTP
bound form. Residues are labelled according to S. cerevisiae numbering. (F) Superimposition of E. coli RlmA(I) (grey) onto Mtq2-Trm112
heterodimer (same colour code as Figure 1A). The residues from RlmA(I) and Trm112 involved in zinc coordination are depicted as sticks. The
SAM molecule bound to Mtq2 is shown as yellow sticks. The zinc atoms bound to RlmA(I) and Trm112 are depicted as grey and purple spheres,
respectively.
6254 Nucleic Acids Research, 2011,Vol.39, No. 14for eRF1 methylation as its substitution by Ala completely
abolishes yeast Mtq2 MTase activity (Table 1). We further
focused our attention on two strictly conserved residues
(Tyr
4 and Asp
9 in Ec-Mtq2, Tyr
15 and Asp
20 in yeast)
from the N-terminal part of Mtq2 that may participate
directly in the coordination of the GGQ motif from
eRF1, according to the superposition of the crystal struc-
ture of PrmC-RF1 complex onto Mtq2 protein. Both
residues are hydrogen-bonded via their side chains and
the aromatic ring from Tyr
15 packs onto the methyl
sulfonio group of the SAM molecule. In order to
analyze their role in eRF1 methylation, we have per-
formed conservative substitution of these residues. The
Tyr
15 side chain was replaced by Phe (Y15F), a substitu-
tion that should not much affect SAM-binding. Asp
20 was
replaced by the isosteric Asn side chain (D20N). Both
mutants proved to be completely inactive (Table 1).
In addition, this conserved region displays a negative
electrostatic potential that very likely compensates for
the positive electrostatic potential surrounding the eRF1
GGQ motif (Figure 2C). We generated several charge in-
version mutants of negatively charged residues from this
highly conserved putative active site: E16K, E19K, D26K/
E29K and E212K (for clarity, yeast numbering is used
in this section unless speciﬁcally stated). We also tested
the following substitutions: F22A, R207A and R207E.
Activity measurements show that all the strictly conserved
residues located along the solvent exposed face of Mtq2
helix a1 (Glu
19, Phe
22, Asp
26 and Glu
29) are crucial
for eRF1 methylation, suggesting that this helix is
directly involved in substrate recognition (Table 1). This
structure-based site-directed mutagenesis approach maps
the Mtq2-Trm112 active site to a highly conserved and
negatively charged region. This is particularly interesting,
since a model of the S. cerevisiae eRF1-eRF3-GTP
complex shows that the eRF1 GGQ motif is surrounded
by highly conserved and basic residues (see ‘Discussion’
section).
Three additional Mtq2 mutants of solvent-exposed
residues affect signiﬁcantly eRF1 methylation. These are
E16K from the loop preceding helix a1 as well as R207A
and R207E from strand b6. These residues are located on
both sides of helix a1 and hence deﬁne a relatively large
substrate-binding site. Other mutated positions from
Mtq2 (E212K) and Trm112 (A106E, E107K, I118E,
Y120E and N123R) affect only partially (50–75%)
MTase activity (Table 1). This notably suggests that
Trm112 may also participate in substrate binding by this
heterodimeric MTase.
The structure of the Mtq2-Trm112 complex can serve
as a model for the Trm9-Trm112 complex
Trm112 interacts with and activates three class I SAM-
dependent MTases: Mtq2, Trm9 and Trm11. These
MTases seem to compete for binding to Trm112, suggest-
ing that they interact with Trm112 in a similar manner
(22,27,30–32,36). Hence, our structure of the Mtq2-
Trm112 complex may serve as a good model for the
Trm9-Trm112 and Trm11-Trm112 complexes and provide
a template for functional studies.
To validate this hypothesis, we have studied the
Trm9-Trm112 complex from S. cerevisiae by using K.
lactis zymocin toxicity as a tool. This toxin speciﬁcally
cleaves some tRNAs at the wobble uridine (U34)
position. In order to be recognized by the zymocin, these
tRNAs need to be fully modiﬁed and Trm9 is one of the
enzymes involved (45). Hence, this toxin kills wild-type
but not S. cerevisiae trm9- or trm112- strains. Using
bioinformatics (see Supplementary Data for details on
Trm9 model generation), we have generated a model for
the S. cerevisiae Trm9 3D-structure and superimposed it
onto Mtq2 in the Mtq2-Trm112 complex. We used this
model to generate two mutant strains (N89K/L91R and
F105E) aimed at disrupting the Trm9-Trm112 interface.
As a positive control, we also generated a third mutant
strain by substituting the strictly conserved aspartic acid
residue proposed to be involved in SAM-binding by
Ala (D72A) to inactivate Trm9 as previously done in
other MTases (46). We then tested the effect of zymocin
addition on cultures of wild-type and mutant yeast strains.
All three mutants are resistant to zymocin supporting
the hypothesis that these Trm9 mutants are inactive
(Figure 3A). Next, the ability of these mutants to
interact in vivo with Trm112 was assessed by co-immuno-
precipitation. Whereas Trm112 co-immunoprecipitates
with wild-type Trm9, no interaction is detected with the
N89K/L91R or F105E mutants (Figure 3B). These
mutants were expressed at similar levels to wild-type
Trm9 protein in vivo, conﬁrming that these mutations
have no effect on protein stability. We therefore, conclude
that these mutations confer the zymocin resistance pheno-
type by disrupting the Trm9–Trm112 interaction.
However, Trm112 still co-immunoprecipitates with the
Trm9 D72A mutant. The zymocin resistance phenotype
is here due to the lack of SAM-binding necessary for a
normal Trm9 activity. The Trm9–Trm112 interaction is
obviously weaker with the Trm9 D72A mutant than
with wild-type Trm9, suggesting SAM-binding by Trm9
may inﬂuence the strength of interaction between Trm9
and Trm112.
Altogether, these experiments strongly support the hy-
pothesis that Trm112 interacts individually with Mtq2,
Trm9 and Trm11 and in a similar way. Hence, the struc-
ture of the Trm112-Mtq2 complex provides a good model
for further mutagenesis studies of the Trm9-Trm112 and
Trm11-Trm112 complexes.
DISCUSSION
Post-synthetic modiﬁcations are widespread and contrib-
ute largely to proteome expansion. Here, we focused our
interest on Trm112, a small eukaryotic protein interacting
with and activating three SAM-dependent MTases
involved in protein synthesis. Two (Trm9 and Trm11)
modify tRNAs and the remaining (Mtq2) acts on the
class I translation termination factor eRF1 (5,31,34).
The crystal structure of the Mtq2-Trm112 complex from
E. cuniculi shows that Mtq2 is composed of a single class I
SAM-dependent MTase domain also found in PrmC but
does not possess the equivalent of the PrmC N-terminal
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PrmC-RF1 structure onto the Mtq2-Trm112 complex
clearly shows that Trm112 is not a structural stand-in for
the PrmC N-terminal domain (Supplementary Figure S6).
Comparison of the active sites of PrmC and Mtq2
shows that the NPPY signature found in MTases modify-
ing nitrogen atoms conjugated to planar systems perfectly
superpose and is at the centre of a region highly conserved
in eukaryotes. This superposition further shows how the
Gln side chain from the eRF1 GGQ motif should be
trapped into the Mtq2 active site via a hydrogen
bonding network similar to that observed in PrmC-RF1
structure (Figure 2A). Additional structural overlap exists
between the loop connecting strand b2 from the short
b-hairpin to helix a6 from the MTase domain in PrmC
and the N-terminal region preceding helix a1 in Mtq2. In
the PrmC-RF1 complex, this loop stacks onto the SAM/
SAH molecule and the Gln side chain by contributing a
hydrophobic side chain (Leu
89 or Phe
100 in E. coli or
Thermotoga maritima PrmC, respectively). The corres-
ponding residue (Tyr
4 or Tyr
15 according to E. cuniculi
and S. cerevisiae yeast numbering, respectively) is strictly
conserved across Mtq2 orthologues. The side chain from
Tyr
4 lies against the SD atom and methyl donor group
from SAM and may form a charge-dipole interaction
with the positively charged SD from SAM. In addition,
its hydroxyl group is hydrogen-bonded to the strictly
conserved Asp
9 side chain (Asp
20 in S. cerevisiae,
Figure 2B and Supplementary Figure S4). Site-directed
mutagenesis of these residues in yeast (Y15F or D20N
mutants) results in complete loss of eRF1 MTase
activity, supporting their crucial role in Mtq2 function
(Table 1). A Tyr residue equivalent to Tyr
4 from
EcMtq2 has also been shown to be important for the
activity of the D1 catalytic subunit of the vaccinia virus
mRNA capping enzyme (Tyr
555) (47).
Next, using site-directed mutagenesis, we have identiﬁed
highly conserved and negatively charged residues (Glu
16,
Glu
19, Asp
26, Asp
29 and Glu
212) surrounding the NPPY
signature from Mtq2 as important for enzymatic activity
(Figure 2C and D and Table 1). A model of the S.
cerevisiae eRF1-eRF3-GTP complex obtained from the
structures of human eRF1-eRF3 (lacking the GTPase
domain) (48) and Dom34-Hbs1-GTP complexes (49,50)
allows us to propose an explanation for the speciﬁcity of
Mtq2-Trm112 for the eRF1-eRF3-GTP complex as sub-
strate. First, the GGQ motif from eRF1 central domain is
surrounded by several conserved Lys/Arg residues
from eRF1 itself. Several of these positively charged
residues may be involved in enzyme-substrate complex
formation through an interaction with the negatively
charged active site of Mtq2. Second, at least one Lys or
Arg residue from the eRF1 helix following the GGQ motif
(probably Arg189 in S. cerevisiae eRF1 and Arg192 in
human eRF1 according to studies conducted on human
proteins), (48) should interact with and stabilize the
eRF3 switch I region and thereby enhance eRF3 afﬁnity
for GTP. This should also stabilize the eRF1 central
domain and in particular the GGQ motif and/or
optimize the orientation and position of the GGQ motif
into Mtq2 active site. Finally, in the eRF1-eRF3-GTP
complex, helix a4 from the switch I region (which
contains four to ﬁve strictly or highly conserved Lys/Arg
residues) of the eRF3 GTPase domain is in close proxim-
ity from eRF1 GGQ motif and hence, could be involved in
Mtq2-Trm112 binding (Figure 2E). As the switch I region
from GTPases adopts drastically different conformations
depending on the bound guanine nucleotide, this inter-
action should be speciﬁc for the eRF3-GTP form,
rationalizing our previous observation that the Mtq2-
Trm112 substrate is the eRF1-eRF3 complex bound to
GTP but not GDP (5,22). Further studies will be
required to determine the mechanism of substrate recog-
nition by Mtq2-Trm112.
Finally, mutations of several solvent exposed Trm112
residues (A106E, E107K, I118E, Y120E and N123R;
Figure 3. Saccharomyces cerevisiae Trm9 mutants exhibit induced resistance to zymocin and are affected in in vivo interaction with Trm112. (A)
Zymocin killer assay on S. cerevisiae strains. Percentage of growth in the presence of K. lactis AWJ137 supernatant containing zymocin was
calculated relative to the control assay performed with supernatant from K. lactis NK40 strain that does not produce zymocin. (B) Effect of
Trm9 mutations on Trm9/Trm112 in vivo interaction. Soluble protein extracts (Input: 1/50th of total proteins, i.e. 10mg) and immunoprecipitates
(IP: 1/10th of immunoprecipitated material) were subjected to 15% SDS–PAGE analysis and immunoblotted using anti-Myc (Trm9-13Myc) and
anti-HA (Trm112-3HA) as primary antibodies and sheep anti mouse HRP-conjugated IgG as secondary antibody. Similar results were obtained
using anti-HA antibodies for protein pull-down (data not shown). The Trm9 D72A mutant protein exhibits a higher electrophoretic mobility due to
its reduced copy number of Myc epitopes that is indicated by asterisk (11 instead of 13 for all other Trm9 variants).
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disrupting complex formation and fold (data not shown).
Strikingly, the protein displaying the higher structural
similarity with the Mtq2-Trm112 complex is the bacterial
protein RlmA(I), which is involved in methylation of
23S rRNA at position G745 (51). RlmA(I) is composed
of an N-terminal zinc ﬁnger domain followed by a
C-terminal class I MTase domain (52). Superposition of
the RlmA(I) MTase domain onto the Mtq2 protein
(RMSD of 2.6 A ˚ over 120 Ca atoms, 7% sequence
identity) in our complex reveals that the Trm112 zinc
ﬁnger domain nicely matches with the RlmA(I) zinc
ﬁnger domain that has been suggested to interact with
the rRNA substrate (Figure 2F) (52). This suggests that
Trm112 may assist Mtq2 in substrate recognition. Such
structural similarity with RlmA(I) was previously pro-
posed for the Tmr11-Trm112 complex (RMSD between
our crystal structure and the Trm11-Trm112 model is
2.35 A ˚ over 191 Ca atoms) (31).
The Mtq2-Trm112 structure also suggests how Trm112
activates Mtq2 and hence its other MTase partners. First,
Trm112 masks a hydrophobic region from Mtq2 upon
complex formation, explaining the need for co-expression
of Trm112 and Mtq2 to solubilize Mtq2 (Supplementary
Figure 3D and E) (22). The same mechanism may be
shared by Trm9, which can only be recovered as a
soluble protein upon co-expression with Trm112 (22,27)
(M.G. and V.H.H., unpublished data). Second, Trm112
stimulates SAM-binding by Mtq2 via its interaction with
the Mtq2 loop connecting strands b3–b4, which in turn
contacts the SAM molecule (Figure 1B and C). Moreover,
the Trm9 mutant (D72A) predicted to be deﬁcient in
SAM-binding interacts more weakly with Trm112 than
wild-type Trm9 (Figure 3B). Altogether, this strongly
argues in favour of a synergistic interaction between
SAM, Trm112 and Mtq2/Trm9. We project that Trm112
may assist substrate binding by its three partners. Indeed,
as mentioned above, we have identiﬁed mutations of
solvent-exposed Trm112 residues affecting eRF1 methyla-
tion by Mtq2 (Table 1). However, the implication of
Trm112 in the recognition of substrates as different as
tRNA and eRF1/eRF3 will need to be further addressed.
The requirement for a protein partner to activate MTases
is not unique to Trm112 but was described for the follow-
ing holoenzymes Trm8-Trm82, Trm61-Trm6, vaccinia
virus D1-D12 capping enzyme (46,53–57). The vaccinia
virus D12 activator subunit stabilizes the D1 subunit, in-
creases its catalytic activity and its afﬁnity for both its
substrate and SAM (57). Regarding the Trm8-Trm82
complex, which catalyses m
7G methylation at position
46 of some tRNAs (58), Trm82 is not directly involved
in tRNA binding but should rather stabilize Trm8 by
modulating the structure of its catalytic site (53,59). In
the Trm61-Trm6 complex, Trm6 is required for tRNA
binding and hence catalysis of A58 methylation by the
Trm61 MTase (54,56).
Several observations support the hypothesis that
Trm112 interacts in a similar way with its three MTase
partners. First, sequence analysis predicts that Mtq2,
Trm9 and Trm11 belong to the same structural family of
class I SAM-dependent MTases (3,31,34). Second,
over-expression of Mtq2 or Trm11 affects the interaction
between Trm9 and Trm112, thereby inhibiting Trm9
activity and consequently conferring resistance to
zymocin (36). This is in line with previous results indi-
cating that Trm112 interacts independently with its
partners (31). Third, the b-zipper type of interaction
between strands b4 from Trm112 and b3 from Mtq2
(Figure 1A and Supplementary Figure 3A) involves
hydrogen bonds between main chain atoms and may
therefore be well adapted for interaction with proteins
with totally different sequences but similar folds.
Fourth, mutations of Trm9 residues (N89K/L91R and
F105E) corresponding to Mtq2 residues involved in the
interface with Trm112 confer resistance to zymocin (i.e.
inactivate Trm9) and disrupt interaction with Trm112
(Figure 3A and B). Altogether, these observations
strongly argue in favour of a similar interaction mode
between Trm112 and its three MTase partners. It is note-
worthy that the Trm9–Trm112 interaction is conserved in
human, since the tRNA MTase domain from human
Trm9 also interacts with human Trm112 (29,32).
Similarly, Mtq2 and Trm112 proteins are conserved in
eukaryotes and archaea and their interaction has been
shown in yeast and mammals. Their deletion has a
strong impact on growth and development but it is not
known if this is a direct consequence of the absence of
eRF1 methylation, leading to a termination defect
during protein synthesis. Indeed, the absence of methyla-
tion does not inﬂuence signiﬁcantly in vivo readthrough in
yeast and could even have an opposite effect (26) (VHH,
SF unpublished results). In addition, it has been shown
that increased stop codon readthrough in eRF1 mutants
or [PSI
+] and yeast variants does not lead to a reduction in
growth rate (60–62). In yeast, TRM112 deletion is more
detrimental than the combined deletions of known
partners (Mtq2, Trm9, Trm11), suggesting another
function for Trm112. Preliminary results suggest that an
interaction between Trm112 and Sfh1, an essential com-
ponent of the RSC complex involved in transcription and
necessary for proper mitosis, might be biologically
relevant (27). Clearly, more studies aimed at deciphering
the role of Trm112 are needed and our crystal structure of
the Mtq2-Trm112 complex provides an excellent template
for designing future experiments towards this goal.
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